Assessment of iron metabolism and iron deficiency in incident patients on incident continuous ambulatory peritoneal dialysis

被引:0
作者
Yin, Qinghua [1 ]
Guo, Na [2 ]
Fu, Ping [1 ]
Zhong, Hui [1 ]
机构
[1] Sichuan Univ, West China Hosp, Kidney Res Inst, Div Nephrol, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp 2, Dept Pediat, Div Nephrol, Chengdu 610041, Sichuan, Peoples R China
来源
OPEN MEDICINE | 2024年 / 19卷 / 01期
关键词
peritoneal dialysis; serum ferritin; ferritin saturation; iron deficiency; inflammation; ANEMIA; ROXADUSTAT; PHASE-3; CKD; MEGAKARYOPOIESIS; DISEASE; ALPHA;
D O I
10.1515/med-2024-1035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The aim of this study was to investigate iron status and iron deficiency in incident continuous ambulatory peritoneal dialysis (CAPD) patients and identify influencing factors. Methods - Patients with end-stage renal disease were enrolled. Clinical data of iron metabolism and biochemical and dialysis parameters during the first peritoneal dialysis evaluation were collected. Serum ferritin (SF) and transferrin saturation (TSAT) levels were evaluated, and independent influencing factors were identified by correlation and regression analyses. Results - Of 1,128 adult CAPD patients, 41.2% had iron deficiency (ID), 15.7% had absolute iron deficiency, and 8.2% had functional iron deficiency. The average SF level was (276.8 +/- 277.9) mu g/L, and iron saturation was (29.8 +/- 12.7)%. Additionally, 50.2 and 69.3% of patients reached targets in SF level and iron saturation recommended by the Chinese Society of Nephrology. SF level and TSAT were not correlated with estimated glomerular filtration rate, whereas negatively correlated with platelet count and inflammatory factors. Low platelet count, presence of diabetes mellitus and high interleukin 6 levels were independent factors of lower TSAT. Conclusions - ID is common in patients with CAPD. Women and those with thrombocytopenia, diabetes, and inflammation are at higher risk for iron storage or reduced iron utilization. In the initial CAPD stage, a reasonable iron supplement strategy may be established for CAPD patients with high-risk factors.
引用
收藏
页数:8
相关论文
共 23 条
  • [1] Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKD
    Akizawa, Tadao
    Iwasaki, Manabu
    Otsuka, Tetsuro
    Yamaguchi, Yusuke
    Reusch, Michael
    [J]. KIDNEY INTERNATIONAL REPORTS, 2021, 6 (07): : 1810 - 1828
  • [2] Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
    Akizawa, Tadao
    Iwasaki, Manabu
    Yamaguchi, Yusuke
    Majikawa, Yoshikatsu
    Reusch, Michael
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (07): : 1628 - 1639
  • [3] Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease
    Aksan, Ayseguel
    Wohlrath, M.
    Iqbal, Tariq H.
    Dignass, A.
    Stein, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (03) : 316 - 322
  • [4] THE IRON BIOLOGY STATUS OF PERITONEAL DIALYSIS PATIENTS MAY BE A RISK FACTOR FOR DEVELOPMENT OF INFECTIOUS PERITONITIS
    Aldriwesh, Marwh
    Al-Dayan, Noura
    Barratt, Jonathan
    Freestone, Primrose
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2019, 39 (04): : 362 - 374
  • [5] Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
    Chen, N.
    Hao, C.
    Liu, B-C
    Lin, H.
    Wang, Caili
    Xing, C.
    Liang, X.
    Jiang, G.
    Liu, Zhengrong
    Li, X.
    Zuo, L.
    Luo, L.
    Wang, J.
    Zhao, M.
    Liu, Zhihong
    Cai, G-Y
    Hao, L.
    Leong, R.
    Wang, Chunrong
    Liu, C.
    Neff, T.
    Szczech, L.
    Yu, K-H P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (11) : 1011 - 1022
  • [6] Association of Abnormal Iron Status with the Occurrence and Prognosis of Peritoneal Dialysis-Related Peritonitis: A Longitudinal Data-Based 10-Year Retrospective Study
    Diao, Xiangwen
    Zheng, Zhiwei
    Yi, Chunyan
    Cao, Peiyi
    Ye, Hongjian
    Liu, Ruihua
    Lin, Jianxiong
    Chen, Wei
    Mao, Haiping
    Huang, Fengxian
    Yang, Xiao
    [J]. NUTRIENTS, 2022, 14 (08)
  • [7] Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin
    Evstatiev, Rayko
    Bukaty, Adam
    Jimenez, Kristine
    Kulnigg-Dabsch, Stefanie
    Surman, Lidia
    Schmid, Werner
    Eferl, Robert
    Lippert, Kathrin
    Scheiber-Mojdehkar, Barbara
    Kvasnicka, Hans Michael
    Khare, Vineeta
    Gasche, Christoph
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (05) : 524 - 529
  • [8] Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study
    Fishbane, Steven
    Pollock, Carol A.
    El-Shahawy, Mohamed
    Escudero, Elizabeth T.
    Rastogi, Anjay
    Van, Bui Pham
    Frison, Lars
    Houser, Mark
    Pola, Maksym
    Little, Dustin J.
    Guzman, Nicolas
    Pergola, Pablo E.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (04): : 850 - 866
  • [9] Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
    Fishbane, Steven
    El-Shahawy, Mohamed A.
    Pecoits-Filho, Roberto
    Van, Bui Pham
    Houser, Mark T.
    Frison, Lars
    Little, Dustin J.
    Guzman, Nicolas J.
    Pergola, Pablo E.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (03): : 737 - 755
  • [10] Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018
    Fishbane, Steven
    Spinowitz, Bruce
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (03) : 423 - 435